Renal damage in tuberous sclerosis


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The review presents a modern concept of renal manifestations in tuberous sclerosis. Surgical and medical treatment modalities are described.

Texto integral

Acesso é fechado

Bibliografia

  1. Bissler J.J., Henske E.P. In: Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics. Germany: Wiley-VCH, 2010. P. 327-344.
  2. Cho N.H., Shim H.S., Choi Y.D., Kim D.S. Estrogen receptor is significantly associated with the epithelioid variants of renal angiomyolipoma: A clinicopathological and immunohistochemical study of 67 cases. Pathology International. 2004; 54: 510-515.
  3. Colombat M., Boccon-Gibod L., Carton S. An unusual renal angiomyolipoma with morphological lymphangiomyomatosis features and coexpression of estrogen and progesterone receptors. Virchows Arch. 2002; 440: 102-104.
  4. Crino P.B., Nathanson K.L., Henske E.P. The tuberous sclerosis complex. N. Engl. J. Med. 2006; 355: 1345-1356.
  5. Roach E.S., Whittemore V.H. Diagnosis, screening and Clinical care of individuals with Tuberous sclerosis. Tuberous Sclerosis Alliance. 2011; 28-32.
  6. Eble J.N. Angiomyolipoma of kidney. Semin. Diagn. Pathol. 1998; 15: 21.
  7. Schillinger F., Montagnac R. Chronic renal failure and its treatment in tuberous sclerosis. Nephrol. Dial. Transplant. 1996; 11: 481.
  8. El-Hashemite N., Zhang H., Henske E.P., Kwiatkowski D.J. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet. 2003; 361: 1348-1349.
  9. Fernández Arjona M., Minguez R., Serrano P., Sanz J., Teba F., Peinado F., Nieto S., Pereira I. Rapidly-growing renal angiomyolipoma associated with pregnancy. Actas Urol. Esp. 1994; 18: 755.
  10. Halpenny D., Snow A., McNeill G., Torreggiani W.C. The radiological diagnosis and treatment of renal angiomyolipoma-current status. Clin. Rad. 2010; 65: 99-108.
  11. Henske E.P., Ao X., Short M.P., Greenberg R., Neumann H.P., Kwiatkowski D.J., Russo I. Frequent progesterone receptor immunoreactivity in tuberous sclerosis-associated renal angiomyolipomas. Mod. Pathol. 1998; 11: 665.
  12. Inoki K., Corradetti M.N., Guan K.L. Dysregulation of the TSCmTOR pathway in human disease. Nat. Genet. 2005; 37: 19-24.
  13. Byrd G.F., Lawatsch E.J., Mesrobian H.G., Begun F., Langenstroer P. Laparoscopic cryoablation of renal angiomyolipoma. J. Urol. 2006; 176(4): 1512-1516.
  14. L 'Hostis H., Deminiere C., Ferriere J.M., Coindre J.M. Renal angiomyolipoma. A clinicopathologic immunohistochemical, and follow-up study of 46 cases. Am. J. Surg. Pathol. 1999; 23: 1011-1020.
  15. Logginidou H., Ao X., Russo I., Henske E.P. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangiomyomatosis. Chest. 2000; 117: 25-30.
  16. Frost M., Budde K., Kingswood J.C., Zonnenberg B., Belousova E., Rdzikowska E., Sauter M., Nonomura N., Brakemeier S., de Vries P., Sahmou T., Shah G., Miao S., Lincy J., Bissler J.J. EXIST-2 Examining everolimus in a study of TSC).
  17. Mourikis D., Chatziioannou A., Antoniou A., Kehagias D., Gikas D., Vlahos L. Selective arterial embolization in the management of symptomatic renal angiomyolipomas. Eur. J. Radiol. 1999; 32: 153.
  18. Nelson C.P., Sanda M.G. Contemporary diagnosis and management of renal angiomyolipoma. J. Urol. 2002; 168: 1315-1325.
  19. O'Callaghan F.J.K., Shiell A.W., Osborne J.P., Martyn C.N. Prevalence of tuberous sclerosis estimated by capture-recapture analysis. Lancet. 1998; 351(9114): 1490.
  20. Petri H.E., Ao X., Short P., Greenberg R., Neumann H.P., Kwiatkowski D.J., Russo I. Frequent progesterone receptor immunoreactivity in tuberous sclerosis-associated renal angiomyolipomas. Mod. Pathol. 1998; 11: 665-668.
  21. Rakowski S.K., Winterkorn E.B., Paul E., Steele D.J., Halpern E.F., Thiele E.A. Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. Kidney Int. 2006; 70: 1777-1782.
  22. Sampson J.R., Maheshwar M.M., Aspenwall R., Thomson P. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am. J. Hum. Genet. 1997; 61: 843-851.
  23. Shillinger F., Montagnac R. Chronic renal failure and its treatment in tuberous sclerosis. Nephrol. Dial. Transplant. 1996; 11: 481-485.
  24. Stillwell T.J., Gomez M.R., Kelalis P.P. Renal lesions in tuberous sclerosis. J. Urol. 1987; 138: 477-481.
  25. Taylor R.S., Joseph D.B., Kohaut E.C., Wilson E.R., Bueschen A.J. Renal angiomyolipoma associated with lymph node involvement and renal cell carcinoma in patients with tuberous sclerosis. J. Urol. 1989; 141: 930.
  26. Yamakado K., Tanaka N., Nakagawa T., Kobayashi S., Yanagawa M., Takeda K. Renal angiomyolipoma: relationships between tumor size, aneurysm formation and rupture. Radiology. 2002; 225(1): 78-82.
  27. Дорофеева М.Ю., Страхова О.С., Катышева О.В., Осипова Э.К., Чумак О.И., Добрынина М.В. Туберозный склероз. Лечащий врач. 2005; 8.
  28. Шнайдер Н.А., Максимова Ю.В., Максимов В.Н., Дмитренко Д.В., Шаповалова Е.А. Туберозный склероз (болезнь Бурневилля-Прингла): Учебное пособие с грифом УМО Министерства образования РФ для системы последипломного образования врачей. Под ред. Н.А. Шнайдер, Ю.В. Максимовой. Красноярск, 2010. 112 с.
  29. Волкова М.И. Ангиомиолипома: таргетные препараты vs хирургическое мастерство. Урология сегодня. 2014; 4.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies